A state court jury in the USA has ruled that pharma giant Pfizer (NYSE: PFE) was not responsible for the birth defects in a child whose mother used Zoloft (sertraline) during pregnancy.
The jury rejected claims by the plaintiff that Pfizer had neglected to properly disclose the risk of birth defects associated with the antidepressant. This follows a state court decision in April where the St Louis court also determined Pfizer was not liable.
This is just one of more than 1000 cases pending in state and federal courts in the USA. The plaintiff is seeking $2.4 million in compensation and argues that her daughter’s heart abnormalities were caused by the use of Zoloft in pregnancy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze